A Phase I trial evaluating safety, PK and initial antiviral activity of EYP001 in subjects with chronic hepatitis B virus infection.
Phase of Trial: Phase I
Latest Information Update: 28 Dec 2016
At a glance
- Drugs EYP 001 (Primary)
- Indications Hepatitis B
- Focus Adverse reactions
- 28 Dec 2016 New trial record
- 19 Dec 2016 According to a Poxel media release, this trial is expected to be initiated in 2017.